ADIPOQ and obesity due to melanocortin 4 receptor deficiency: It should be mentioned that several studies have shown that the pharmacological reconstitution of adiponectin levels through drugs targeting adiponectin synthesis would help in the treatment of obesity and the associated diabetes and cardiovascular disease (Achari and Jain, 2017).